IQV

IQVIA Holdings Inc

207.65

Jul 02 • 02:20PM ET +4.45 (2.19%)

Healthcare Diagnostics & Research USA Large NYSE

Peers: ICLR NTRA DHR TMO LH A WAT IDXX MTD BIO

| Held by: VTI VOO VO IVV SPY VTV XLV RSP VOE IWR

Scroll to Statements

Index	S&P 500
Market Cap	34.66B
Enterprise Value	48.75B
Income	1.39B
Sales	16.63B
Book/sh	37.27
Cash/sh	12.60
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	93000
IPO	May 09, 2013

P/E	25.74
Forward P/E	14.67
PEG	1.52
P/S	2.08
P/B	5.57
P/C	16.48
P/FCF	16.38
EV/EBITDA	13.95
EV/Sales	2.93
Quick Ratio	0.75
Current Ratio	0.75
Debt/Eq	2.58
LT Debt/Eq	2.29
Option/Short	Yes / Yes

EPS (ttm)	8.07
EPS next Y	14.16
EPS next Q	3.04
EPS this Y	7.53%
EPS next Y	10.46%
EPS next 5Y	9.67%
EPS past 3/5Y	11.05% 40.52%
Sales past 3/5Y	4.18% 7.50%
EPS Y/Y TTM	9.79%
Sales Y/Y TTM	7.33%
EPS Q/Q	14.97%
Sales Q/Q	8.56%
Earnings	May 05 BMO
EPS/Sales Surpr.	2.97% 1.24%

Insider Own	0.98%
Insider Trans	0.00%
Inst Own	101.88%
Inst Trans	-0.44%
ROA	4.86%
ROE	22.71%
ROIC	6.78%
Gross Margin	25.97%
Oper. Margin	13.99%
Profit Margin	8.33%
SMA20	12.84%
SMA50	17.98%
SMA200	6.26%
Trades

Shs Outstand	166.90M
Shs Float	165.26M
Short Float	3.04%
Short Ratio	2.98
Short Interest	5.03M
52W High	247.04 -15.95%
52W Low	154.50 34.40%
Volatility	3.69% 3.76%
ATR (14)	7.21
RSI (14)	73.72
Beta	1.19
Rel Volume	0.40
Avg Volume	1.69M
Volume	513,048

Perf Week	11.38%
Perf Month	14.95%
Perf Quarter	20.45%
Perf Half Y	-8.80%
Perf YTD	-7.88%
Perf Year	26.12%
Perf 3Y	-7.62%
Perf 5Y	-16.66%
Perf 10Y	210.57%
Recom	1.52
Target Price	224.17
Prev Close	203.20
Price	207.65
Change	2.19%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-17-26	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$200
Mar-09-26	Upgrade	TD Cowen	Hold → Buy	$213
Mar-06-26	Upgrade	Barclays	Equal Weight → Overweight	$210
Mar-03-26	Initiated	RBC Capital Mkts	Outperform	$221
Dec-02-25	Resumed	Morgan Stanley	Overweight	$265
Nov-13-25	Initiated	BMO Capital Markets	Outperform	$260
Nov-03-25	Downgrade	TD Cowen	Buy → Hold	$215
Oct-29-25	Upgrade	Robert W. Baird	Neutral → Outperform	$258
Oct-09-25	Upgrade	HSBC Securities	Hold → Buy	$235
Sep-09-25	Upgrade	Jefferies	Hold → Buy	$225
Apr-25-25	Downgrade	HSBC Securities	Buy → Hold	$160
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight	$170
Feb-03-25	Downgrade	BTIG Research	Buy → Neutral
Dec-20-24	Initiated	Stephens	Overweight	$250
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform	$275
Jul-24-24	Downgrade	Jefferies	Buy → Hold	$266 → $242
Jun-06-24	Initiated	Goldman	Buy	$270
Feb-26-24	Initiated	Leerink Partners	Outperform	$290
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral

Show Previous Ratings

Jun-24-26 04:30PM	IQVIA Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch) +8.37%
Jun-17-26 09:47AM	Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls (The Fly)
09:13AM	Morgan Stanley favors Charles River Over IQVIA in CRO sector reset (Investing.com)
Jun-15-26 09:00AM	Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain (Business Wire)
Jun-04-26 10:51AM	IQVIA Announces Pricing of Senior Notes (Business Wire)
08:38AM	Loading…
08:38AM	Is Veeva Stock Undervalued At $170? (Trefis)
Jun-03-26 02:53AM	IQVIA Announces Offering of Senior Notes (Business Wire)
May-28-26 04:30PM	IQVIA Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch) +9.34%
May-26-26 04:15PM	IQVIA CEO to Speak at Jefferies Global Healthcare Conference (Business Wire)
May-13-26 04:30PM	IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities (Business Wire)
May-07-26 05:15PM	IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization (Business Wire)
May-06-26 04:15PM	IQVIA CFO to Speak at Bank of America Health Care Conference 2026 (Business Wire)
May-05-26 12:51PM	IQVIA Holdings Inc. Q1 2026 Earnings Call Summary (Moby) +9.62%
07:14AM	IQVIA: Q1 Earnings Snapshot (Associated Press)
07:00AM	IQVIA Reports First-Quarter 2026 Results (Business Wire)
11:46AM	Loading…
Apr-24-26 11:46AM	Eli Lilly Stock Falls. Foundayo Is Fighting to Catch Novo's Wegovy Pill. (Barrons.com)
Apr-15-26 04:15PM	IQVIA to Announce First-Quarter 2026 Results on May 5, 2026 (Business Wire)
04:05PM	Lilly Stock Dips on FDA Request for More Foundayo Safety Data. Is the Market Reaction Overblown? (Barrons.com)
Mar-16-26 04:30PM	IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences (Business Wire)
Mar-10-26 02:38PM	IQVIA Holdings Inc. (IQV) Advances Clinical Research and Data Capabilities to Drive Growth (Insider Monkey)
10:01AM	Is IQVIA Holdings Stock Underperforming the Nasdaq? (Barchart)
Mar-09-26 09:33AM	Netflix resumed, Starbucks downgraded: Wall Street's top analyst calls (The Fly)
Mar-04-26 10:08AM	Jim Cramer on IQVIA: "I Like the Business Very Much, I Just Don't Know Whether This Is the Right Stock to Play It" (Insider Monkey)
Mar-03-26 09:33AM	MongoDB downgraded, Block upgraded: Wall Street's top analyst calls (The Fly)
Mar-02-26 04:30PM	IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference (Business Wire)
04:15PM	IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference (Business Wire)
12:13PM	Can AI Acceleration and R&D Strength Drive VEEV Ahead of Q4 Earnings? (Zacks)
Mar-01-26 04:24AM	Analysts at Mizuho Remain Bullish on IQVIA (IQV) Following Q4 Results (Insider Monkey)
Feb-27-26 04:47PM	IQVIA Releases its 2025 Sustainability Report (Business Wire)
Feb-26-26 11:53PM	Is IQVIA Holdings Inc. (IQV) a Buy Post Earnings? (Insider Monkey) +5.39%
09:03AM	Loading…
09:03AM	IQVIA Holdings (IQV) Rallied on Waning Concerns Over Biotech Funding and Clinical Activity (Insider Monkey)
06:42AM	IQVIA to acquire Charles River drug discovery assets (Pharmaceutical Technology)
Feb-25-26 11:08PM	3 Reasons to Sell IQV and 1 Stock to Buy Instead (StockStory)
09:06AM	Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans (Benzinga)
07:00AM	IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities (Business Wire)
Feb-24-26 02:33PM	IQVIA Holdings Inc. (IQV) Offers Impressive Upside Despite AI-Linked Threats (Insider Monkey)
Feb-21-26 10:39AM	Morgan Stanley Lowers its Price Target on IQVIA Holdings Inc. (IQV) to $240 but Maintains an Overweight Rating (Insider Monkey)
Feb-19-26 10:36AM	TransUnion Stock Gains 6% Post Reporting Q4 Earnings & Revenue Beat (Zacks)
05:38AM	Is Wall Street Bullish or Bearish on IQVIA Holdings Stock? (Barchart)
Feb-18-26 04:15PM	IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day (Business Wire)
09:15AM	Unlocking IQVIA (IQV) International Revenues: Trends, Surprises, and Prospects (Zacks)
Feb-17-26 11:46AM	Waste Connections Stock Slides 7% Since Q4 Earnings Beat Estimates (Zacks)
Feb-13-26 08:32AM	Is the Options Market Predicting a Spike in IQVIA Stock? (Zacks)
Feb-12-26 12:30PM	Insperity Stock Price Decreases 18% After Reporting Loss in Q4 (Zacks)
12:36AM	The Top 5 Analyst Questions From IQVIA's Q4 Earnings Call (StockStory)
Feb-11-26 07:19PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Feb-10-26 08:00AM	IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions (Business Wire) -5.30%
Feb-08-26 08:39AM	Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? (Benzinga)
Feb-06-26 07:21PM	IQVIA Q4 Earnings Call Highlights (MarketBeat)
09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
12:54AM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
12:35AM	IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis (StockStory)
Feb-05-26 04:00PM	IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -10.65%
12:11PM	IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y (Zacks)
11:55AM	IQVIA (IQV) Stock Trades Down, Here Is Why (StockStory)
09:07AM	IQVIA backs AI strategy as analysts question impact on business (Reuters)
08:15AM	IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates (Zacks)
07:36AM	IQVIA's (NYSE:IQV) Q4 CY2025 Sales Top Estimates (StockStory)
07:20AM	IQVIA: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance (Business Wire)
Feb-04-26 11:40AM	IQV or IDXX: Which Is the Better Value Stock Right Now? (Zacks)
Feb-03-26 10:14PM	IQVIA (IQV) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory) -11.88%
11:23AM	IQVIA Set to Report Q4 Earnings: Here's What You Should Know (Zacks)
09:15AM	Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics (Zacks)
Jan-29-26 08:00AM	IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration (Business Wire)
Jan-25-26 11:44AM	Beyond Biotech-3 Healthcare Stocks for Growth-Minded Investors (MarketBeat)
Jan-22-26 04:05PM	IQVIA Named to the Fortune Worlds Most Admired Companies List, Ranked No. 1 in Its Sector for Fifth Consecutive Year (Business Wire)
Jan-20-26 04:45PM	IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026 (Business Wire)
Jan-15-26 09:36AM	3 Medical Device Companies in Focus for Monetizing Data and Analytics (Zacks)
Jan-14-26 09:50AM	Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term (Zacks)
Jan-13-26 09:11AM	What You Need To Know Ahead of IQVIAs Earnings Release (Barchart)
Jan-12-26 11:36PM	2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down (StockStory)
Jan-11-26 11:04PM	3 Reasons to Sell IQV and 1 Stock to Buy Instead (StockStory)
Jan-09-26 09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
Dec-29-25 12:55PM	Here's Why You Should Retain IQV Stock in Your Portfolio Now (Zacks)
Dec-17-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-09-25 10:19AM	Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run? (Zacks)
09:50AM	Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-04-25 12:21PM	Why This FDA Shake-Up Rattled Medpace And Iqvia, But Buoyed Viking Therapeutics (Investor's Business Daily)
Dec-03-25 10:32PM	Is IQVIA Holdings Stock Outperforming the S&P 500? (Barchart)
Dec-02-25 08:00AM	IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform (Business Wire)
Nov-28-25 11:30AM	Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-27-25 11:30AM	Why Is IQVIA (IQV) Up 6.4% Since Last Earnings Report? (Zacks)
Nov-26-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Nov-11-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Nov-06-25 10:32PM	Q3 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
12:38PM	GDOT Gears Up to Report Q3 Earnings: Here's What You Should Know (Zacks)
12:33PM	Mogo Set to Report Q3 Earnings: Here's What Investors Should Know (Zacks)
Nov-05-25 04:15PM	Dr. William G. Kaelin Jr. joins IQVIA Board of Directors (Business Wire)
09:40AM	IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Nov-04-25 12:31AM	IQVIA's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Nov-03-25 01:15PM	Why IQVIA (IQV) Shares Are Trading Lower Today (StockStory)
09:42AM	Boeing upgraded, Charter downgraded: Wall Street's top analyst calls (The Fly)
Oct-30-25 03:14PM	IQVIA Holdings Inc (IQV) Q3 2025 Earnings Call Highlights: Record Free Cash Flow and Strong ... (GuruFocus.com)
Oct-29-25 03:45PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
01:31AM	IQV Q3 Deep Dive: Clinical Research Demand and AI Initiatives Drive Steady Growth (StockStory)
Oct-28-25 08:00PM	IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
01:09PM	IQVIA Earnings & Revenues Beat Estimates in Q3, Increase Y/Y (Zacks)
08:15AM	IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates (Zacks)
07:28AM	IQVIA (NYSE:IQV) Beats Q3 Sales Expectations (StockStory)

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission-critical information, technology solutions, and real-world evidence services to the company's life sciences clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial-related services. The Contract Sales and Medical Solutions segment offers healthcare provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1950 and is headquartered in Durham, NC.

CEO & ChairmanMr. Ari Bousbib

Executive VPMr. Eric M. Sherbet J.D.

President of Research & Development SolutionsMr. W. Richard Staub III

President of Commercial SolutionsMr. Alistair Grenfell

Executive VP & Chief Financial OfficerMr. Michael J. Fedock MBA

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOUSBIB ARI	See Remarks	Dec 18 '25	Option Exercise	59.90	50,000	2,995,000	857,163	Dec 19 05:00 PM
BOUSBIB ARI	See Remarks	Dec 18 '25	Sale	222.43	36,564	8,132,931	820,599	Dec 19 05:00 PM
ARI BOUSBIB	Officer	Dec 18 '25	Proposed Sale	222.43	36,564	8,132,876		Dec 18 05:41 PM
Sherbet Eric	See Remarks	Oct 29 '25	Option Exercise	131.82	10,000	1,318,200	31,108	Oct 31 05:01 PM
Sherbet Eric	See Remarks	Oct 29 '25	Sale	219.70	4,000	878,800	27,108	Oct 31 05:01 PM
BOUSBIB ARI	See Remarks	Oct 29 '25	Option Exercise	59.90	77,592	4,647,761	884,755	Oct 31 05:00 PM
BOUSBIB ARI	See Remarks	Oct 29 '25	Sale	220.33	56,557	12,461,119	828,198	Oct 31 05:00 PM
ARI BOUSBIB	Officer	Oct 29 '25	Proposed Sale	220.33	56,557	12,460,983		Oct 29 04:18 PM
ERIC SHERBET	Officer	Oct 29 '25	Proposed Sale	219.70	4,000	878,820		Oct 29 04:10 PM
Cherofsky Keriann	See Remarks	Jul 23 '25	Sale	191.53	549	105,150	2,910	Jul 25 05:01 PM
Sherbet Eric	See Remarks	Jul 23 '25	Option Exercise	97.20	11,870	1,153,764	32,978	Jul 25 05:00 PM
Sherbet Eric	See Remarks	Jul 23 '25	Sale	190.05	5,800	1,102,290	27,178	Jul 25 05:00 PM
ERIC SHERBET	Officer	Jul 23 '25	Proposed Sale	190.05	5,800	1,102,262		Jul 23 05:53 PM
KERIANN CHEROFSKY	Officer	Jul 23 '25	Proposed Sale	191.53	549	105,150		Jul 23 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

IQV

IQVIA Holdings Inc

Upgrade your Finviz experience